/ Pre-IPO Risk Index / Lyra Health

Lyra Health

Healthcare (Mental Health) · Pre-IPO · $5.6B (Q3 2022, secondary 2024 suggests stable)
B

Good (B) — Round Z Pre-IPO Risk Grade

Lyra Health operates the leading enterprise mental-health benefits platform, serving Fortune 500 customer base. Strong revenue retention and disciplined valuation.

81
Composite / 100
/ Subscore Breakdown · 5 Dimensions

Where this grade comes from.

Governance Risk
B+
Valuation Methodology
B
Secondary Liquidity
B-
Financial Disclosure
B
Exit Probability
B
/ Public-Record Events

Key risk events & disclosures.

  • Fortune 500 customer adoption: Apple, Starbucks, Morgan Stanley, etc.
  • $5.6B 2022 valuation stable through 2024 secondary trades
  • Profitable unit economics on enterprise plans
  • Strategic Salesforce Ventures participation

/ Best for

Investors seeking enterprise mental-health exposure with mature Fortune 500 customer base and disciplined valuation trajectory.

/ Watch out for

Spring Health, Headspace Health, and Modern Health competitive pressure in the same enterprise category.